Vectura Group PLC (LON:VEC) had its price target reduced by J P Morgan Chase & Co from GBX 210 ($2.83) to GBX 180 ($2.43) in a research report released on Thursday. They currently have an overweight rating on the stock.

A number of other brokerages also recently commented on VEC. Numis Securities Ltd restated a buy rating and set a GBX 205 ($2.76) target price on shares of Vectura Group PLC in a report on Thursday, September 7th. N+1 Singer restated a hold rating on shares of Vectura Group PLC in a report on Thursday, June 29th. Peel Hunt restated a hold rating and set a GBX 160 ($2.16) target price on shares of Vectura Group PLC in a report on Thursday, June 29th. Shore Capital restated a buy rating on shares of Vectura Group PLC in a report on Wednesday, August 16th. Finally, Citigroup Inc. decreased their target price on Vectura Group PLC from GBX 200 ($2.70) to GBX 180 ($2.43) and set a buy rating for the company in a report on Monday. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have given a buy rating to the stock. Vectura Group PLC has a consensus rating of Buy and a consensus price target of GBX 199.63 ($2.69).

Vectura Group PLC (VEC) traded up 0.10% during mid-day trading on Thursday, hitting GBX 100.20. 806,768 shares of the stock traded hands. Vectura Group PLC has a 1-year low of GBX 88.90 and a 1-year high of GBX 166.97. The company has a 50-day moving average of GBX 107.83 and a 200 day moving average of GBX 125.26. The firm’s market capitalization is GBX 679.86 million.

TRADEMARK VIOLATION WARNING: This article was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this article on another publication, it was illegally copied and reposted in violation of international copyright and trademark legislation. The original version of this article can be read at https://www.dailypolitical.com/2017/09/22/vectura-group-plc-vec-price-target-cut-to-gbx-180-by-analysts-at-j-p-morgan-chase-co.html.

In other Vectura Group PLC news, insider Andrew Derodra bought 82,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 7th. The shares were bought at an average price of GBX 90 ($1.21) per share, with a total value of £73,800 ($99,501.15). Also, insider Bruno Angelici bought 70,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 12th. The shares were acquired at an average cost of GBX 99 ($1.33) per share, for a total transaction of £69,300 ($93,434.00). Insiders have purchased a total of 152,293 shares of company stock worth $14,339,837 in the last three months.

About Vectura Group PLC

Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company’s products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) – LABA-LAMA; Seebri Breezhaler (EU and RoW) – LAMA; AirFluSal Forspiro (EU and RoW) – ICS-LABA; ADVATE (Global) – Antihaemophilic Factor (Recombinant); Adept (Global) – Icodextrin; Anoro Ellipta (Global) – LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) – ICS-LABA, and Incruse Ellipta (Global) – LAMA.

Analyst Recommendations for Vectura Group PLC (LON:VEC)

Receive News & Ratings for Vectura Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.